Risk factors for myocarditis associated with immune checkpoint inhibitors using real-world clinical data.

被引：0

作者：

Jain, Prantesh

Bugarin, Jahir Gutierrez

Guha, Avirup

Jain, Chhavi

Shen, Tingke

Stanevich, Ilya

Margevicius, Seunghee P.

Fu, Pingfu

Liu, Fang

Nikore, Vipan

Mangla, Ankit

De Lima, Marcos J. G.

Velcheti, Vamsidhar

Barnholtz-Sloan, Jill

Dowlati, Afshin

机构：

[1] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA

[2] Case Western Reserve Univ, Cleveland, OH 44106 USA

[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA

[4] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[5] Cleveland Clin, Cleveland, OH 44106 USA

[6] Case Comprehens Canc Ctr, Cleveland, OH USA

[7] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[8] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA

[9] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA

[10] Case Western Reserve Univ, Case Comprehens Canc Ctr, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e15100

引用

页数：2

共 50 条

[21] Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan
Manako, Tomomi
Yasumatsu, Ryuji
Nakano, Takafumi
Matsuo, Mioko
Takeuchi, Toranishin
Taura, Masahiko
Tamae, Akihiro
Yamauchi, Moriyasu
Masuda, Muneyuki
Taguchi, Kenichi
Nakagawa, Takashi
IN VIVO, 2023, 37 (02): : 747 - 755
[22] Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia
Al Nuhait, Mohammed
Bajnaid, Eshtyag
Al Otaibi, Abdulmalik
Al Shammari, Abdullah
Al Awlah, Yousef
SCIENCE PROGRESS, 2021, 104 (01)
[23] Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
She, Jianqing
Liu, Hui
Wu, Haoyu
Tuerhongjiang, Gulinigaer
Zheng, Tao
Bai, Ling
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[24] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Bol, Kalijn Fredrike
Ellebaek, Eva
Hoejberg, Lise
Bagger, Mette Marie
Larsen, Mathilde Skaarup
Klausen, Tobias Wirenfeldt
Kohler, Ulrich Heide
Schmidt, Henrik
Bastholt, Lars
Kiilgaard, Jens Folke
Donia, Marco
Svane, Inge Marie
CANCERS, 2019, 11 (10)
[25] Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
Yang, Yana
Li, Linman
Tian, Jing
Ma, Linwen
Wu, Yaoxin
Luo, Qian
Luo, Yan
FRONTIERS IN PHARMACOLOGY, 2024, 15
[26] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
Bol, K. F.
Ellebaek, E.
Donia, M.
Schmidt, H.
Bastholt, L.
Kiilgaard, J. F.
Svane, I-M.
ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
[27] Consistent Patterns of Immune-Related Adverse Events in Postmortem and Real-World Data on Immune Checkpoint Inhibitors
Frey, Connor
MODERN PATHOLOGY, 2025, 38 (04)
[28] Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
Ruggiero, Rosanna
Stelitano, Barbara
Fraenza, Federica
di Mauro, Gabriella
Scavone, Cristina
Sportiello, Liberata
Rafaniello, Concetta
Di Napoli, Raffaella
Danesi, Romano
Del Re, Marzia
Rossi, Francesco
Capuano, Annalisa
FRONTIERS IN ONCOLOGY, 2022, 12
[29] Early Mortality Associated Factors With Immune Checkpoint Inhibition in Real-World Canadian NSCLC Patients
Gibson, A.
Meyers, D.
Dean, M.
Stukalin, I.
Morris, D.
Bebb, D. G.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S348 - S348
[30] Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis
Chen, Xue
Jiang, Aimin
Zhang, Rui
Fu, Xiao
Liu, Na
Shi, Chuchu
Wang, Jingjing
Zheng, Xiaoqiang
Tian, Tao
Liang, Xuan
Ruan, Zhiping
Yao, Yu
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9

← 1 2 3 4 5 →